• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在细胞培养生产过程中鉴定和防止抗体中二硫键还原。

Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.

机构信息

Genentech, Inc., South San Francisco, California 94080, USA.

出版信息

Biotechnol Bioeng. 2010 Jun 15;106(3):452-61. doi: 10.1002/bit.22699.

DOI:10.1002/bit.22699
PMID:20178122
Abstract

In the biopharmaceutical industry, therapeutic monoclonal antibodies are primarily produced in mammalian cell culture systems. During the scale-up of a monoclonal antibody production process, we observed excessive mechanical cell shear as well as significant reduction of the antibody's interchain disulfide bonds during harvest operations. This antibody reduction event was catastrophic as the product failed to meet the drug substance specifications and the bulk product was lost. Subsequent laboratory studies have demonstrated that cells subjected to mechanical shear release cellular enzymes that contribute to this antibody reduction phenomenon (manuscript submitted; Kao et al., 2009). Several methods to prevent this antibody reduction event were developed using a lab-scale model to reproduce the lysis and reduction events. These methods included modifications to the cell culture media with chemicals (e.g., cupric sulfate (CuSO(4))), pre- and post-harvest chemical additions to the cell culture fluid (CCF) (e.g., CuSO(4), EDTA, L-cystine), as well as lowering the pH and air sparging of the harvested CCF (HCCF). These methods were evaluated for their effectiveness in preventing disulfide bond reduction and their impact to product quality. Effective prevention methods, which yielded acceptable product quality were evaluated for their potential to be implemented at manufacturing-scale. The work described here identifies numerous effective reduction prevention measures from lab-scale studies; several of these methods were then successfully translated into manufacturing processes.

摘要

在生物制药行业,治疗性单克隆抗体主要在哺乳动物细胞培养系统中生产。在单克隆抗体生产工艺放大过程中,我们在收获操作过程中观察到过度的机械细胞剪切以及抗体间二硫键的显著减少。这种抗体减少事件是灾难性的,因为产品未能达到药物物质规格,大量产品损失。随后的实验室研究表明,受到机械剪切的细胞释放出细胞酶,这些酶导致了这种抗体减少现象(已提交手稿;Kao 等人,2009 年)。使用实验室规模模型重现裂解和减少事件,开发了几种防止这种抗体减少事件的方法。这些方法包括用化学物质(例如硫酸铜 (CuSO(4)))修改细胞培养基、在细胞培养液 (CCF) 中进行收获前和收获后的化学添加(例如 CuSO(4)、EDTA、L-半胱氨酸),以及降低 pH 值和收获的 CCF(HCCF)中的空气吹气。评估了这些方法在防止二硫键减少方面的有效性及其对产品质量的影响。评估了有效的预防方法,以确定其在制造规模上实施的潜力,这些方法产生了可接受的产品质量。这里描述的工作从实验室研究中确定了许多有效的减少预防措施;然后成功地将其中几种方法转化为制造工艺。

相似文献

1
Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.在细胞培养生产过程中鉴定和防止抗体中二硫键还原。
Biotechnol Bioeng. 2010 Jun 15;106(3):452-61. doi: 10.1002/bit.22699.
2
Air sparging for prevention of antibody disulfide bond reduction in harvested CHO cell culture fluid.采用空气喷射法防止收获的中国仓鼠卵巢(CHO)细胞培养液中抗体二硫键还原
Biotechnol Bioeng. 2015 Apr;112(4):734-42. doi: 10.1002/bit.25495. Epub 2014 Dec 23.
3
Mechanism of antibody reduction in cell culture production processes.抗体在细胞培养生产工艺中的减少机制。
Biotechnol Bioeng. 2010 Nov 1;107(4):622-32. doi: 10.1002/bit.22848.
4
Aggregates in monoclonal antibody manufacturing processes.单克隆抗体生产工艺中的聚集物。
Biotechnol Bioeng. 2011 Jul;108(7):1494-508. doi: 10.1002/bit.23155. Epub 2011 Apr 20.
5
Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.在生产过程中使用过氧化氢来防止抗体中二硫键还原。
MAbs. 2018 Apr;10(3):500-510. doi: 10.1080/19420862.2018.1424609. Epub 2018 Jan 23.
6
Thioredoxin 1 is responsible for antibody disulfide reduction in CHO cell culture.硫氧还蛋白 1 负责 CHO 细胞培养中抗体的二硫键还原。
J Biotechnol. 2012 Jan;157(1):261-7. doi: 10.1016/j.jbiotec.2011.11.009. Epub 2011 Nov 25.
7
Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability.抗体二硫键还原对纯化工艺性能及最终药物稳定性的影响。
Biotechnol Bioeng. 2017 Jun;114(6):1264-1274. doi: 10.1002/bit.26265. Epub 2017 Mar 6.
8
Controlling trisulfide modification in recombinant monoclonal antibody produced in fed-batch cell culture.控制补料分批细胞培养中生产的重组单克隆抗体中的三硫键修饰。
Biotechnol Bioeng. 2012 Oct;109(10):2523-32. doi: 10.1002/bit.24511. Epub 2012 Apr 9.
9
A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.CHO 细胞中单克隆抗体生产的高通量预测性缩小模型。
Biotechnol Bioeng. 2009 Dec 15;104(6):1107-20. doi: 10.1002/bit.22474.
10
Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process.开发快速高效的筛选方法,以用于重组单克隆抗体生产工艺中高性能水解产物批的筛选。
Biotechnol Prog. 2012 Jul;28(4):1061-8. doi: 10.1002/btpr.1568. Epub 2012 Jun 22.

引用本文的文献

1
Machine learning-driven optimization of culture conditions and media components to mitigate charge heterogeneity in monoclonal antibody production: current advances and future perspectives.机器学习驱动的培养条件和培养基成分优化以减轻单克隆抗体生产中的电荷异质性:当前进展与未来展望
MAbs. 2025 Dec;17(1):2547084. doi: 10.1080/19420862.2025.2547084. Epub 2025 Aug 14.
2
Detecting features of antibody structure through their mediator-accessible redox activities.通过抗体的介质可及氧化还原活性检测其结构特征。
Nat Chem Biol. 2025 Feb;21(2):291-299. doi: 10.1038/s41589-024-01778-z. Epub 2024 Dec 2.
3
Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies.
开发一种用于治疗性单克隆抗体中结构域特异性游离巯基鉴定和定量的新型无标记亚基亲水相互作用液相色谱-质谱方法。
J Am Soc Mass Spectrom. 2024 Dec 4;35(12):3019-3027. doi: 10.1021/jasms.4c00308. Epub 2024 Oct 30.
4
New high-throughput screening method for Chinese hamster ovary cell lines expressing low reduced monoclonal antibody levels: application of a system controlling the gas phase over cell lysates in miniature bioreactors and facilitating multiple sample setup.用于表达低还原单克隆抗体水平的中国仓鼠卵巢细胞系的新型高通量筛选方法:在微型生物反应器中控制细胞裂解物上方气相并便于进行多样品设置的系统的应用。
Cytotechnology. 2023 Oct;75(5):421-433. doi: 10.1007/s10616-023-00587-x. Epub 2023 Jul 21.
5
Manipulation of mRNA translation elongation influences the fragmentation of a biotherapeutic Fc-fusion protein produced in CHO cells.调控 mRNA 翻译延伸过程会影响 CHO 细胞表达的生物治疗性 Fc 融合蛋白的碎片化。
Biotechnol Bioeng. 2022 Dec;119(12):3408-3420. doi: 10.1002/bit.28230. Epub 2022 Sep 18.
6
A Review of Methodologies for the Detection, Quantitation, and Localization of Free Cysteine in Recombinant Proteins: A Focus on Therapeutic Monoclonal Antibodies.重组蛋白中游离半胱氨酸的检测、定量和定位方法综述:聚焦治疗性单克隆抗体
Front Mol Biosci. 2022 Jun 27;9:886417. doi: 10.3389/fmolb.2022.886417. eCollection 2022.
7
Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies.IgG1 和 IgG4 抗体中二硫键还原的机制见解。
Appl Microbiol Biotechnol. 2022 Feb;106(3):1057-1066. doi: 10.1007/s00253-022-11778-5. Epub 2022 Jan 24.
8
Untargeted proteomics reveals upregulation of stress response pathways during CHO-based monoclonal antibody manufacturing process leading to disulfide bond reduction.非靶向蛋白质组学揭示 CHO 基单克隆抗体生产过程中应激反应途径的上调,导致二硫键还原。
MAbs. 2021 Jan-Dec;13(1):1963094. doi: 10.1080/19420862.2021.1963094.
9
Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.单克隆抗体治疗药物中小分子工艺相关杂质的安全性风险管理:利用清除潜能进行分类、风险评估、测试策略和工艺开发。
Biotechnol Prog. 2021 May;37(3):e3119. doi: 10.1002/btpr.3119. Epub 2021 Jan 6.
10
Toward Drug-Like Multispecific Antibodies by Design.通过设计实现类似药物的多特异性抗体。
Int J Mol Sci. 2020 Oct 12;21(20):7496. doi: 10.3390/ijms21207496.